Potassium Chloride (IV)
Brand names: KCl, Potassium Chloride Infusion
Intravenous potassium chloride is a concentrated electrolyte preparation used to treat or prevent hypokalaemia in patients who cannot be managed by the oral route.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It replaces the potassium ion, the principal intracellular cation essential for resting membrane potential, neuromuscular conduction and cardiac rhythm, correcting the consequences of potassium depletion.
Prescribing in practice
- Concentrated potassium chloride is a high-risk medicine that must always be diluted and given as a controlled-rate infusion, never as a bolus or rapid push, because inadvertent rapid administration can cause fatal cardiac arrest.
- Use ready-diluted preparations where possible and infuse faster or more concentrated solutions only with continuous cardiac monitoring, ideally via a central line for stronger concentrations.
- Caution is required in renal impairment and when co-prescribed with potassium-retaining drugs such as ACE inhibitors, ARBs and potassium-sparing diuretics, given the risk of hyperkalaemia.
Monitoring
Monitor serum potassium and renal function regularly, with ECG/cardiac monitoring during higher-rate or more concentrated infusions.
Counselling the patient
- This is a potassium replacement given slowly through a drip to correct a low blood level.
- It is always diluted and never given quickly because of the risk to the heart.
- Pain or stinging at the drip site should be reported, as the solution can irritate the vein.
Evidence & guidelines
Concentrated potassium chloride is recognised as a high-alert medicine, and UK patient-safety guidance (NPSA) mandates restricted storage and controlled dilution and infusion to prevent fatal medication errors.
Reference: NPSA Patient Safety Alert 2002 (Potassium Chloride); ICU electrolyte replacement protocols; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Glucose Infusion Rate (GIR) Calculator · Glucose Management
- Hyponatraemia Cause Algorithm · Electrolyte Disorders
- Hyperkalaemia Management Algorithm · Electrolyte Disorders
- Heparin Infusion Dose Calculator · Anticoagulation
- Donor Lymphocyte Infusion (DLI) Volume and Dose Calculator · Stem Cell Transplant
- Transtubular Potassium Gradient (TTKG) · Electrolytes